Delfi Diagnostics
$34.3M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Delfi Diagnostics is currently valued at N/A as of December 18, 2025. The company has raised a total of $465.9M in funding.
Investment Perspective
Delfi Diagnostics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Delfi Diagnostics Worth in 2025?
As of 2025, Delfi Diagnostics is valued at N/A, based on the company's Later Stage VC funding round in December 18, 2025. This valuation positions Delfi Diagnostics as one of the leading private companies in the sector.
Delfi Diagnostics Valuation History
Delfi Diagnostics's funding history demonstrates steady growth and investor confidence.
How Delfi Diagnostics Valuation is Determined
Private company valuations like Delfi Diagnostics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Delfi Diagnostics Valuation FAQs
Is Delfi Diagnostics profitable?
Delfi Diagnostics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Delfi Diagnostics's valuation compare to competitors?
Delfi Diagnostics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Delfi Diagnostics IPO?
Delfi Diagnostics has not announced plans for an initial public offering. Until an IPO, investors can access Delfi Diagnostics shares through secondary market platforms.